New familial forms of cerebral amyloid and dementia

Molecular Psychiatry

Volumn 5, Issue 6, 2000, Pages 575-576

  Vidal, R ^a   Ghiso, J ^a   Frangione, B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; CLINICAL FEATURE; DEGENERATIVE DISEASE; DEMENTIA; FAMILIAL DISEASE; HUMAN; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOIDOSIS; BRAIN; FAMILY HEALTH; HUMANS; POINT MUTATION;

EID: 0033653177     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000797     Document Type: Article

References (14)

1. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset
2. New order from neurological disorders
3. Biology of Aβ amyloid in Alzheimer's disease
4. Molecular genetics of Alzheimer's disease
5. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
6. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
7. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1
8. Proteolytic processing and cell biological functions of the amyloid precursor protein
9. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
10. A stop-codon mutation in the BRI gene associated with familial British dementia
11. A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred
12. Familial cerebral amyloid angiopathy with nonneuritic plaque formation
13. Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic plaque formation
14. Alzheimer disease: Mouse models pave the way for therapeutic opportunities